Deciphera Pharmaceuticals, Inc. (DCPH) News

Deciphera Pharmaceuticals, Inc. (DCPH): $47.00

-0.23 (-0.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DCPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 494

in industry

Filter DCPH News Items

DCPH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DCPH News Highlights

  • DCPH's 30 day story count now stands at 1.
  • list("500 - Internal server error")
  • The most mentioned tickers in articles about DCPH are STEP.

Latest DCPH News From Around the Web

Below are the latest news stories about Deciphera Pharmaceuticals Inc that investors may wish to consider to help them evaluate DCPH as an investment opportunity.

Is DCPH Stock A Buy or Sell?

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]

Yahoo | April 8, 2021

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 PM ET. The conference will be held in a virtual meeting format. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/ne

Business Wire | March 2, 2021

Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 4:20 PM ET. The conference will be held in a virtual meeting format. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investo

Business Wire | February 18, 2021

Broker Revenue Forecasts For Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Are Surging Higher

Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) shareholders will have a reason to smile today, with the analysts...

Yahoo | February 11, 2021

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate update and highlighted key 2021 milestones in conjunction with its presentation at the 39th Annual J.P. Morgan Virtual Healthcare Conference. The Company will webcast its presentation today at 9:10 AM ET at https://investors.deciphera.com/news-events/events-presentations

Business Wire | January 11, 2021

Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 AM ET. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will b

Business Wire | January 5, 2021

DCPH Stock Forecast: Where Do Hedge Funds Stand?

In this article you are going to find out whether hedge funds think Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]

Yahoo | December 21, 2020

Medison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize QINLOCK® (Ripretinib) in a Multi-Regional Agreement

PETACH TIKVA, Israel and WALTHAM, Mass., Nov. 6, 2020 /PRNewswire/ -- Medison Pharma, a leading international commercial partner for highly innovative therapies, today announced an exclusive distribution agreement with Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) to commercialize…

PR Newswire | November 6, 2020

Deciphera Pharmaceuticals Earnings and Growth Analysis : Stock market Insights & financial analysis

Deciphera Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…

Stock Market Daily | November 5, 2020

Deciphera Pharmaceuticals (NASDAQ:DCPH) Rating Increased to Buy at BidaskClub

Deciphera Pharmaceuticals (NASDAQ:DCPH) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, BidAskClub reports. DCPH has been the subject of a number of other research reports. Zacks Investment Research downgraded shares of Deciphera Pharmaceuticals from a “buy” rating to […]

Zolmax News | October 25, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7241 seconds.